Attovia Therapeutics’ $105 Million Oversubscribed Series B Financing

Fenwick & West represented Attovia Therapeutics in the transaction.Attovia Therapeutics (“Attovia”), a developer of a pipeline of biotherapeutics with an initial focus on immune-mediated diseases, announced…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here